227 related articles for article (PubMed ID: 29242193)
1. Crystal structure of murine 4-1BB and its interaction with 4-1BBL support a role for galectin-9 in 4-1BB signaling.
Bitra A; Doukov T; Wang J; Picarda G; Benedict CA; Croft M; Zajonc DM
J Biol Chem; 2018 Jan; 293(4):1317-1329. PubMed ID: 29242193
[TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the m4-1BB/4-1BBL complex reveals an unusual dimeric ligand that undergoes structural changes upon 4-1BB receptor binding.
Bitra A; Doukov T; Destito G; Croft M; Zajonc DM
J Biol Chem; 2019 Feb; 294(6):1831-1845. PubMed ID: 30545939
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures of the human 4-1BB receptor bound to its ligand 4-1BBL reveal covalent receptor dimerization as a potential signaling amplifier.
Bitra A; Doukov T; Croft M; Zajonc DM
J Biol Chem; 2018 Jun; 293(26):9958-9969. PubMed ID: 29720398
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the human 4-1BB/4-1BBL complex.
Gilbreth RN; Oganesyan VY; Amdouni H; Novarra S; Grinberg L; Barnes A; Baca M
J Biol Chem; 2018 Jun; 293(25):9880-9891. PubMed ID: 29720399
[TBL] [Abstract][Full Text] [Related]
5. Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BB.
Loo DT; Chalupny NJ; Bajorath J; Shuford WW; Mittler RS; Aruffo A
J Biol Chem; 1997 Mar; 272(10):6448-56. PubMed ID: 9045669
[TBL] [Abstract][Full Text] [Related]
6. Structure of the 4-1BB/4-1BBL complex and distinct binding and functional properties of utomilumab and urelumab.
Chin SM; Kimberlin CR; Roe-Zurz Z; Zhang P; Xu A; Liao-Chan S; Sen D; Nager AR; Oakdale NS; Brown C; Wang F; Yang Y; Lindquist K; Yeung YA; Salek-Ardakani S; Chaparro-Riggers J
Nat Commun; 2018 Nov; 9(1):4679. PubMed ID: 30410017
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 Decreases 4-1BBL Bioactivity by Crosslinking Soluble and Membrane Expressed 4-1BB.
Nielsen MA; Juul-Madsen K; Stegmayr J; Gao C; Mehta AY; Greisen SR; Kragstrup TW; Hvid M; Vorup-Jensen T; Cummings RD; Leffler H; Deleuran BW
Front Immunol; 2022; 13():915890. PubMed ID: 35812455
[TBL] [Abstract][Full Text] [Related]
8. The structure of the trimer of human 4-1BB ligand is unique among members of the tumor necrosis factor superfamily.
Won EY; Cha K; Byun JS; Kim DU; Shin S; Ahn B; Kim YH; Rice AJ; Walz T; Kwon BS; Cho HS
J Biol Chem; 2010 Mar; 285(12):9202-10. PubMed ID: 20032458
[TBL] [Abstract][Full Text] [Related]
9. Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells.
Zhao Y; Croft M
Immunol Lett; 2012 Jan; 141(2):220-6. PubMed ID: 22037570
[TBL] [Abstract][Full Text] [Related]
10. Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab.
Li Y; Tan S; Zhang C; Chai Y; He M; Zhang CW; Wang Q; Tong Z; Liu K; Lei Y; Liu WJ; Liu Y; Tian Z; Cao X; Yan J; Qi J; Tien P; Gao S; Gao GF
Cell Rep; 2018 Oct; 25(4):909-920.e4. PubMed ID: 30355497
[TBL] [Abstract][Full Text] [Related]
11. Constitutive interaction between 4-1BB and 4-1BBL on murine LPS-activated bone marrow dendritic cells masks detection of 4-1BBL by TKS-1 but not 19H3 antibody.
Mbanwi AN; Lin GHY; Wang KC; Watts TH
J Immunol Methods; 2017 Nov; 450():81-89. PubMed ID: 28789924
[TBL] [Abstract][Full Text] [Related]
12. Expression of 4-1BB and 4-1BBL in thymocytes during thymus regeneration.
Kim YM; Kim HK; Kim HJ; Lee HW; Ju SA; Choi BK; Kwon BS; Kim BS; Kim JB; Lim YT; Yoon S
Exp Mol Med; 2009 Dec; 41(12):896-911. PubMed ID: 19745604
[TBL] [Abstract][Full Text] [Related]
13. Production of recombinant human trimeric CD137L (4-1BBL). Cross-linking is essential to its T cell co-stimulation activity.
Rabu C; Quéméner A; Jacques Y; Echasserieau K; Vusio P; Lang F
J Biol Chem; 2005 Dec; 280(50):41472-81. PubMed ID: 16204238
[TBL] [Abstract][Full Text] [Related]
14. Engineered soluble, trimerized 4-1BBL variants as potent immunomodulatory agents.
Battin C; De Sousa Linhares A; Leitner J; Grossmann A; Lupinek D; Izadi S; Castilho A; Waidhofer-Söllner P; Grabmeier-Pfistershammer K; Stritzker J; Steinberger P
Cancer Immunol Immunother; 2023 Sep; 72(9):3029-3043. PubMed ID: 37310433
[TBL] [Abstract][Full Text] [Related]
15. 4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.
Macdonald DC; Hotblack A; Akbar S; Britton G; Collins MK; Rosenberg WC
J Immunol; 2014 Nov; 193(10):5056-64. PubMed ID: 25305314
[TBL] [Abstract][Full Text] [Related]
16. Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies.
Madireddi S; Eun SY; Lee SW; Nemčovičová I; Mehta AK; Zajonc DM; Nishi N; Niki T; Hirashima M; Croft M
J Exp Med; 2014 Jun; 211(7):1433-48. PubMed ID: 24958847
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of cancer with 4-1BB.
Vinay DS; Kwon BS
Mol Cancer Ther; 2012 May; 11(5):1062-70. PubMed ID: 22532596
[TBL] [Abstract][Full Text] [Related]
18. Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease.
Lin GH; Sedgmen BJ; Moraes TJ; Snell LM; Topham DJ; Watts TH
J Immunol; 2009 Jan; 182(2):934-47. PubMed ID: 19124736
[TBL] [Abstract][Full Text] [Related]
19. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
20. A novel adenovirus expressing human 4-1BB ligand enhances antitumor immunity.
Yoshida H; Katayose Y; Unno M; Suzuki M; Kodama H; Takemura S; Asano R; Hayashi H; Yamamoto K; Matsuno S; Kudo T
Cancer Immunol Immunother; 2003 Feb; 52(2):97-106. PubMed ID: 12594573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
